Investing.com - Smith&Nephew SNATS reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Smith&Nephew SNATS announced earnings per share of $0.78 on revenue of $1.34B. Analysts polled by Investing.com anticipated EPS of $0.65 on revenue of $1.3B.
Smith&Nephew SNATS shares are down 2.63% from the beginning of the year, still down 10.93% from its 52 week high of $46.10 set on January 20. They are under-performing the EUR/USD which is down 0% from the start of the year.
Smith&Nephew SNATS follows other major Healthcare sector earnings this month
Smith&Nephew SNATS's report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar